ImportRefusal LogoImportRefusal

Giuseppa Capitani

⚠️ Moderate Risk

FEI: 3005398592 • Tarquinia • ITALY

FEI

FEI Number

3005398592

📍

Location

Tarquinia

🇮🇹

Country

ITALY
🏢

Address

Via C T Crispi Sn, , Tarquinia, , Italy

Moderate Risk

FDA Import Risk Assessment

26.4
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

3
Total Refusals
5
Unique Violations
12/10/2005
Latest Refusal
12/10/2005
Earliest Refusal

Score Breakdown

Violation Severity
41.7×40%
Refusal Volume
22.3×30%
Recency
0.0×20%
Frequency
30.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

3242×

NO ENGLISH

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use (for example, label contains information in two or more languages but fails to repeat all required information in both languages in accordance with 21 CFR 101.15(c)(2), or label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1), except in the case of articles distributed solely in the Commonwealth of Puerto Rico or in a Territory where the predominant language is one other than English)).

161×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

4721×

NO ENGLISH

Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).

4821×

NUTRIT LBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling fails to bear the required nutrition information.

4831×

DRUG NAME

The article appears to be a drug and fails to bear the proprietary or established name and/or name and quantity of each active ingredient.

Refusal History

DateProductViolationsDivision
12/10/2005
26CCN04OLIVE OIL, REFINED, SINGLE INGREDIENT
324NO ENGLISH
482NUTRIT LBL
New Orleans District Office (NOL-DO)
12/10/2005
32CCP99LIQUORS, N.E.C.
324NO ENGLISH
New Orleans District Office (NOL-DO)
12/10/2005
66VAY99MISCELLANEOUS PATENT MEDICINES, ETC.
16DIRECTIONS
472NO ENGLISH
483DRUG NAME
New Orleans District Office (NOL-DO)

Frequently Asked Questions

What is Giuseppa Capitani's FDA import refusal history?

Giuseppa Capitani (FEI: 3005398592) has 3 FDA import refusal record(s) in our database, spanning from 12/10/2005 to 12/10/2005.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Giuseppa Capitani's FEI number is 3005398592.

What types of violations has Giuseppa Capitani received?

Giuseppa Capitani has been cited for 5 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Giuseppa Capitani come from?

All FDA import refusal data for Giuseppa Capitani is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.